Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, Larosa E, Guize L, Safar M, Soubrier F, Cambien F
INSERM U337, Broussais Hospital, Paris, France.
Circulation. 1996 Aug 15;94(4):698-703. doi: 10.1161/01.cir.94.4.698.
Clinical and experimental studies have demonstrated a major role of the renin-angiotensin system in the functional and structural changes of the large arteries in hypertension. Because genetic studies may help us to understand the mechanisms underlying the involvement of this system in arterial regulation, the present study was designed to assess the contribution of polymorphisms of the ACE insertion/deletion (I/D) and angiotensin II type 1 receptor (AGTR1 A 1166C) genes on aortic stiffness regulation.
This study included 311 untreated hypertensive and 128 normotensive subjects. Aortic stiffness was evaluated by measurement of the carotid-femoral pulse-wave velocity (PWV). In normotensive subjects, the two polymorphisms did not influence any of the studied parameters. In hypertensive subjects, there was a decreasing trend of mean PWV with the number of ACE D alleles, but this association became significant only after adjustment for blood pressure (P < .05). Conversely, the AGTR1 A 1166C polymorphism was independently associated with aortic stiffness. Mean values of PWV were 11.6 +/- 2.7 m/s in AGTR1 AA homozygotes, 13.3 +/- 3.3 m/s in AC heterozygotes, and 15.3 +/- 4.3 m/s in CC homozygotes (P < .0001 and P < .00001 after adjustment for age and mean blood pressure, respectively). The percentage of variance of PWV explained by AGTR1 A 1166C polymorphism (11.6%) was much larger than that of ACE I/D polymorphism (1.7%).
These results suggest that in hypertensive but not normotensive subjects, the AGTR1 and ACE genotypes are involved in the regulation of aortic rigidity. The presence of the AGTR1 C allele is a strong independent determinant of aortic stiffness, whereas presence of the ACE 1 allele is weakly associated with increased stiffness.
临床和实验研究表明,肾素-血管紧张素系统在高血压患者大动脉的功能和结构改变中起主要作用。由于基因研究可能有助于我们了解该系统参与动脉调节的潜在机制,因此本研究旨在评估血管紧张素转换酶插入/缺失(I/D)多态性和血管紧张素II 1型受体(AGTR1 A1166C)基因多态性对主动脉僵硬度调节的作用。
本研究纳入了311例未经治疗的高血压患者和128例血压正常者。通过测量颈股脉搏波速度(PWV)评估主动脉僵硬度。在血压正常者中,这两种多态性不影响任何研究参数。在高血压患者中,平均PWV随ACE D等位基因数量的增加有下降趋势,但仅在调整血压后这种关联才具有统计学意义(P <.05)。相反,AGTR1 A1166C多态性与主动脉僵硬度独立相关。AGTR1 AA纯合子的PWV平均值为11.6±2.7 m/s,AC杂合子为13.3±3.3 m/s,CC纯合子为15.3±4.3 m/s(分别在调整年龄和平均血压后,P <.0001和P <.00001)。AGTR1 A1166C多态性解释的PWV变异百分比(11.6%)远大于ACE I/D多态性(1.7%)。
这些结果表明,在高血压患者而非血压正常者中,AGTR1和ACE基因型参与主动脉僵硬度的调节。AGTR1 C等位基因的存在是主动脉僵硬度的一个强有力的独立决定因素,而ACE 1等位基因的存在与僵硬度增加的相关性较弱。